Becker's Clinical Quality & Infection Control

CLIC_February_March_2025

Issue link: https://beckershealthcare.uberflip.com/i/1533298

Contents of this Issue

Navigation

Page 23 of 23

Le a r n m o re a t n oz i n . c o m /n ova PROTECT EVERY PATIENT SM Nozin ® Nasal Sanitizer ® antiseptic is used for antiseptic skin preparation and helps reduce bacteria that can cause skin infections. Outcomes reported by actual customers. Your results may vary. References: nozin.com/clinical-outcomes. ©2024 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin ® , Nasal Sanitizer ® , Protect Every Patient SM , and NOVA SM are trademarks of Global Life Technologies Corp. Other trademarks are property of their respective owners. Patent nos.: nozin.com/patents REDUCE RISK OF AVOIDABLE INFECTIONS AND ASSOCIATED EXCESS LENGTH OF STAY Nasal colonization is a primary risk factor for healthcare- associated infections (HAIs). The new patient safety paradigm is to make universal nasal decolonization the standard of care, without using antibiotics. This is our Protect Every Patient SM service mission to help with your hospital IP program. In published studies, hospitals using Nozin NOVA SM programs powered by Nozin ® Nasal Sanitizer ® antiseptic report lower infections and significant cost savings. Learn more about how we can help.

Articles in this issue

Links on this page

view archives of Becker's Clinical Quality & Infection Control - CLIC_February_March_2025